imiquimod has been researched along with lu 208075 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, T; Fujishima, K; Furue, M; Kido-Nakahara, M; Miake, S; Nakahara, T; Sakai, S; Tsuji, G; Ulzii, D | 1 |
1 other study(ies) available for imiquimod and lu 208075
| Article | Year |
|---|---|
Topical application of endothelin receptor a antagonist attenuates imiquimod-induced psoriasiform skin inflammation.
Topics: Administration, Topical; Animals; Cytokines; Endothelin Receptor Antagonists; Endothelin-1; Gene Expression Regulation; Humans; Imiquimod; Mice; Phenylpropionates; Psoriasis; Pyridazines; Receptors, Endothelin; Skin | 2020 |